BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12239934)

  • 1. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
    Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
    Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
    Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.
    Qu Q; Wang S; Chen S; Zhou L; Rui JA
    Am Surg; 2014 Feb; 80(2):191-6. PubMed ID: 24480222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
    Stuart KE; Anand AJ; Jenkins RL
    Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
    Zhou J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ; Fan J
    Hepatogastroenterology; 2006; 53(68):275-80. PubMed ID: 16608039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
    Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M; Grazi GL; Principe A; Ravaioli M; Ercolani G; Cescon M; Varotti G; Gardini A; Cavallari A
    Hepatogastroenterology; 2004; 51(56):510-4. PubMed ID: 15086193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
    Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.
    Ikai I; Hatano E; Hasegawa S; Fujii H; Taura K; Uyama N; Shimahara Y
    J Am Coll Surg; 2006 Mar; 202(3):431-8. PubMed ID: 16500247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].
    Sitruk V; Vaysse J; Chevret S; Ganne-Carrie N; Christidis C; Trinchet J; Beaugrand M
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1159-63. PubMed ID: 11173728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
    Villa E; Moles A; Ferretti I; Buttafoco P; Grottola A; Del Buono M; De Santis M; Manenti F
    Hepatology; 2000 Aug; 32(2):233-8. PubMed ID: 10915729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
    Luo JC; Hwang SJ; Wu JC; Li CP; Hsiao LT; Lai CR; Chiang JH; Lui WY; Chang FY; Lee SD
    Cancer; 1999 Sep; 86(5):799-804. PubMed ID: 10463978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].
    Zhou J; Fan J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):3005-8. PubMed ID: 17288818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.